NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Payments, wealth & financial services  /  GoodRx Holdings, Inc.

GoodRx Holdings, Inc.

goodrx.com ↗
84
Latest disclosed NPS
8 Aug 2024
18
NPS entries
15 with a number
150%
NRR
28 Feb 2022
90%
Retention
12 Mar 2021

In their words

“We benefit from very strong provider relationships reflected in our 84 Net Promoter Score and 90% awareness amongst HCPs. We've increased our focus on HCP offices by increasing the doctor kits we ship out and putting over 20x more digital marketing…”
— Scott Wagner, Interim Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q2 2024 · 8 Aug 2024
“And so that's why so many providers refer patients to GoodRx, that's why we have an NPS of 90. We have a product that really, really works.”
— Trevor Bezdek, Chairman, GoodRx Holdings, Inc. · Earnings call, Q1 2023 · 10 May 2023
“This is evidenced by the over 90 NPS score that we have with them. What – the stat we've been talking about today is that with Provider Mode, which we launched last year, we have the 400,000 prescribers now activated in Provider Mode.”
— Doug Hirsch, Co-Founder, Co-Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q4 2022 · 28 Feb 2023

Disclosed NPS over time

Every Net Promoter Score GoodRx Holdings, Inc. has published, by date.

80901002021202220232024909090869086869090909090909084

NPS disclosures (18)

Search the database →

8 May 2026
NPSProgram

We also have incredibly high NPS and brand recognition with prescribers, so they routinely use it in their workflow and in their conversations with patients.

— Wendy Barnes, Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q1 2026 · 8 May 2026
Earnings call, Q1 2026 ↗
7 Nov 2024
NPSProgram

First, GoodRx has a huge consumer and healthcare provider audience that really values what we do, reflected by our notably high net promoter scores.

— Scott Wagner, Interim Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q3 2024 · 7 Nov 2024
Earnings call, Q3 2024 ↗
8 Aug 2024
NPS84

We benefit from very strong provider relationships reflected in our 84 Net Promoter Score and 90% awareness amongst HCPs. We've increased our focus on HCP offices by increasing the doctor kits we ship out and putting over 20x more digital marketing…

— Scott Wagner, Interim Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q2 2024 · 8 Aug 2024
Earnings call, Q2 2024 ↗
9 Aug 2023
NPSProgram

GoodRx’s high consumer and provider net promoter scores, our ability to drive almost $15 billion of consumer savings annually, and the scope of our PBM and retail networks, are all evidence of our valuable role in the healthcare ecosystem.

— Scott Wagner, Interim Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q2 2023 · 9 Aug 2023
Earnings call, Q2 2023 ↗
10 May 2023
NPS90

And so that's why so many providers refer patients to GoodRx, that's why we have an NPS of 90. We have a product that really, really works.

— Trevor Bezdek, Chairman, GoodRx Holdings, Inc. · Earnings call, Q1 2023 · 10 May 2023
Earnings call, Q1 2023 ↗
28 Feb 2023
NPS90

This is evidenced by the over 90 NPS score that we have with them. What – the stat we've been talking about today is that with Provider Mode, which we launched last year, we have the 400,000 prescribers now activated in Provider Mode.

— Doug Hirsch, Co-Founder, Co-Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q4 2022 · 28 Feb 2023
Earnings call, Q4 2022 ↗
8 Nov 2022
NPS90

The 90 NPS with providers and with consumers mean both sets of constituencies are hardly receptive to being approached and being served by us with respect to pharma manufacturers.

— Karsten Voermann, Chief Financial Officer, GoodRx Holdings, Inc. · Earnings call, Q3 2022 · 8 Nov 2022
Earnings call, Q3 2022 ↗
14 Oct 2022
NPS90

GoodRx Provider Mode achieved an NPS of 90 among healthcare providers, establishing value in the HCP community.

— reported by finance.yahoo.com · 14 Oct 2022
finance.yahoo.com ↗
9 May 2022
NPS90

Physicians and health care professionals trust us with a very high provider NPS of 90. Companies look to us as a way to introduce products and services and provide savings to our large and growing audience.

— Trevor Bezdek, Co-Founder and Co-Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q1 2022 · 9 May 2022
Earnings call, Q1 2022 ↗
28 Feb 2022
NPS90

This is evidenced by our increased provider NPS, which is now up to 90. Our simple and honest solutions help patients get the healthcare they need at a price they can afford while also reducing the administrative burden on providers and their staff.

— GoodRx Holdings, Inc. · SEC 8-K filing · filed 28 Feb 2022
SEC 8-K filing ↗
10 Nov 2021
NPS90

Patients trust us, and our consumer NPS of 904 is a testament to the important role we play in their care. Physicians and healthcare professionals trust us, with over 2 million prescribers that have a patient that has used GoodRx and a very high…

— GoodRx Holdings, Inc. · SEC 8-K filing · filed 10 Nov 2021
SEC 8-K filing ↗
12 Aug 2021
NPS86

…healthcare professionals represent about 17% of the people who visit the GoodRx website2 and we’re delighted that healthcare providers reward GoodRx with an NPS of 86.2 We believe that our alignment with providers, and our mutual dedication to…

— GoodRx Holdings, Inc. · SEC 8-K filing · filed 12 Aug 2021
SEC 8-K filing ↗
11 Mar 2021
NPS86

We also have extensive reach and satisfaction with providers with 2 million prescribers in the U.S. having a patient that has used GoodRx and an extremely high provider NPS of 86.

— GoodRx Holdings, Inc. · SEC 8-K filing · filed 11 Mar 2021
SEC 8-K filing ↗
20 Oct 2020
NPS90

GoodRx enjoys high consumer loyalty with a consumer net promoter score of 90.

— reported by marketwatch.com · 20 Oct 2020
marketwatch.com ↗
29 Sep 2020
NPS86

GoodRx reports Net Promoter Score of 86 among healthcare professionals.

— reported by nasdaq.com · 29 Sep 2020
nasdaq.com ↗
22 Sep 2020
NPS90

The value that consumers ascribe to our platform is demonstrated by our high NPS of 90 according to a survey that we conducted in February 2020, which exceeds that of many other well-regarded consumer-centric brands.

— GoodRx Holdings, Inc. · SEC S-1 IPO prospectus · filed 22 Sep 2020
SEC S-1 IPO prospectus ↗
14 Sep 2020
NPS90

The value that consumers ascribe to our platform is demonstrated by our high NPS of 90 according to a survey that we conducted in February 2020, which exceeds that of many other well-regarded consumer-centric brands.

— GoodRx Holdings, Inc. · SEC S-1 IPO prospectus · filed 14 Sep 2020
SEC S-1 IPO prospectus ↗
28 Aug 2020
NPS90

The value that consumers ascribe to our platform is demonstrated by our high NPS of 90 according to a survey that we conducted in February 2020, which exceeds that of many other well-regarded consumer-centric brands.

— GoodRx Holdings, Inc. · SEC S-1 IPO prospectus · filed 28 Aug 2020
SEC S-1 IPO prospectus ↗

Retention disclosures (4)

Open in the retention database →

28 Feb 2022
NRR150%

Net revenue retention (pharma manufacturer solutions): 150% (year-to-date ended December 31, 2021) — “We finished the year with net revenue retention of over 150%...Net revenue retention compares total revenue generated from all pharma manufacturer solutions clients in the year-to-date period ended December 31, 2021”

— GoodRx Holdings, Inc. · SEC 8-K filing · filed 28 Feb 2022
SEC 8-K filing ↗
12 Aug 2021
NRR150%

Net revenue retention (GoodRx pharma manufacturer programs): 150% (YTD June 30, 2021) — “net revenue retention of over 150% year-over-year”

— GoodRx Holdings, Inc. · SEC 8-K filing · filed 12 Aug 2021
SEC 8-K filing ↗
12 Aug 2021
NRR170%

Net revenue retention (Pharma Manufacturer Solutions (specific customer)): 170% (Q2 2021 YTD) — “Our net revenue retention with that customer is 170% year-to-date”

— Bansi Nagji, Head of Pharma Manufacturer Solutions or similar, GoodRx Holdings, Inc. · Earnings call, Q2 2021 · 12 Aug 2021
Earnings call, Q2 2021 ↗
12 Mar 2021
Retention90%

Retention rate (manufacturer solutions): 90% (2020 to 2021) — “our client renewal rate exceeded 90% from 2020 to 2021”

— Trevor Bezdek, Co-Founder and Co-Chief Executive Officer, GoodRx Holdings, Inc. · Earnings call, Q4 2020 · 12 Mar 2021
Earnings call, Q4 2020 ↗

Lighthouse companies in Payments, wealth & financial services

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.